International Journal of Health & Allied Sciences

ORIGINAL ARTICLE
Year
: 2014  |  Volume : 3  |  Issue : 1  |  Page : 14--22

Pharmacological and anti-oxidant evaluation of Aspirin, nimodipine and its combination for anti-Parkinson俟Q製 activity in MPTP induced rat model


Nilesh S Ambhore, Maruthi Prasanna, A Shanish Antony, MN Satish Kumar, K Elango 
 Department of Pharmacology, JSS College of Pharmacy, (A Constituent College of JSS University, Mysore) Rocklands, Ooty, The Nilgiris, Tamil Nadu, India

Correspondence Address:
Nilesh S Ambhore
Department of Pharmacology, JSS College of Pharmacy, Rockland, Elkhill, Ooty 643 001, The Nilgiris, Tamil Nadu
India

Background: Mitochondrial damage and oxidative stress plays important role in Parkinson俟Q製 disease (PD). Mitochondria are very crucial part in the cell and have many cellular functions including the generation of ATP and intracellular calcium (Ca 2+ ) homeostasis. Mitochondria also contribute in the formation of reactive oxygen species (ROS) and activating the programmed cell death response, apoptosis. Usually ROS is eliminated by antioxidants present in body, but in case of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induction all the antioxidants become ineffective. Aim: The present study investigated the effects of the non selective cyclooxygenase (COX) inhibitor aspirin and L-type calcium channel inhibitor nimodipine in the prevention of motor impairments and observed anti-oxidant effects in rats after induction of early phase of Parkinson俟Q製 disease by using neurotoxin MPTP. Materials and Methods: The PD was induced in animals by single injection of MPTP. After 48 hrs of induction animals were treated with aspirin and nimodipine for 60 days, then behavioral, biochemical and antioxidant parameters were evaluated to examine the effectiveness of treatment. Statistical analysis was carried out by using one-way ANOVA followed by Bonferroni multiple comparisons test. Results: The treatment with combination (Aspirin 50mg/kg, Nimodipine 30mg/kg) showed significant (P < 0.001) increase in brain dopamine level, improves the complex I activity and also ameliorate the amount of antioxidant enzymes like superoxide dismutase (SOD), glutathione reductase (GSH), catalase (CAT) and decrease in lipid peroxidation. Conclusions : These results strongly suggest that combination shows a good neuroprotective effect compared to single treatment on motor, biochemical and antioxidant parameters in early phase of Parkinson俟Q製 disease.


How to cite this article:
Ambhore NS, Prasanna M, Antony A S, Satish Kumar M N, Elango K. Pharmacological and anti-oxidant evaluation of Aspirin, nimodipine and its combination for anti-Parkinson's activity in MPTP induced rat model.Int J Health Allied Sci 2014;3:14-22


How to cite this URL:
Ambhore NS, Prasanna M, Antony A S, Satish Kumar M N, Elango K. Pharmacological and anti-oxidant evaluation of Aspirin, nimodipine and its combination for anti-Parkinson's activity in MPTP induced rat model. Int J Health Allied Sci [serial online] 2014 [cited 2021 Mar 7 ];3:14-22
Available from: https://www.ijhas.in/article.asp?issn=2278-344X;year=2014;volume=3;issue=1;spage=14;epage=22;aulast=Ambhore;type=0